UPPSALA, SWEDEN / ACCESSWIRE / March 7, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime, an industry leader in precision-based patient monitoring solutions, today announces its largest...
UPPSALA, SWEDEN / ACCESSWIRE / February 15, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Press release: Uppsala, February 15, 2024. Senzime AB (publ):s Year-end report for January...
UPPSALA, SWEDEN / ACCESSWIRE / February 9, 2024 / Senzime (STO:SEZI)(OTCQX:SNZZF) Senzime invites investors, analysts, and media to a webcast presentation of the fourth...
Depression is like waking up to a rainy, dreary morning, every single day. Activities that previously lightened the mood lose their joy. Instead, every...
MINNEAPOLIS, Dec. 14, 2023 /PRNewswire/ -- Saluda Medical, Inc. ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...
WASHINGTON, Dec. 13, 2023 /PRNewswire/ -- MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm...
NMPA conducted quality inspection on eleven types of medical devices and released the result on November 14, 2023. Twenty manufacturers are found incompliance, including...
UPPSALA, SWEDEN / ACCESSWIRE / November 3, 2023 / Senzime (STO:SEZI) The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are...
Ethical statementFor experiments performed at The University of Tokyo, all methods for animal care and use were approved by the institutional review committees of...
NMPA published 45 standards on September 7, 2023, to guide manufacturers for local type testing, pre-clinical, clinical studies, and regulatory submissions. It includes 6...
The federal agency claims the company’s practices amount to antitrust activity, a new salvo in the government’s scrutiny of health care consolidation that has...
